CABALETTA BIO INC (CABA) Stock Income Statement
NASDAQ:CABA - Nasdaq - US12674W1099 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 134.25M | 125.14M | 74.66M | 54.14M | 46.31M | |||
| Research and Development | 104.27M | 97.20M | 55.42M | 39.30M | 32.49M | |||
| Selling, General, and Administrative Expenses | 29.98M | 27.94M | 19.24M | 14.84M | 13.82M | |||
| Operating Income | -134.25M | -125.14M | -74.66M | -54.14M | -46.31M | |||
| Interest Income/Expense | 7.49M | 9.28M | 6.99M | 1.16M | 20.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -126.76M | -115.86M | -67.67M | -52.98M | -46.29M | |||
| Net Income | -126.76M | -115.86M | -67.67M | -52.98M | -46.29M | |||
| EBITDA | -129.34M | -120.33M | -73.23M | -52.96M | -45.58M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.52 | -2.34 | -1.65 | -1.81 | -1.80 | |||
| Non GAAP EPS | -2.54 | -2.34 | -1.65 | -1.81 | -1.80 | |||
| Statistics | ||||||||
All data in USD